It is used as a daytime tranquilizer in neurotic, psychopathic asthenia, in conditions accompanied by anxiety, fear (including before surgical interventions and painful diagnostic examinations), increased irritability, sleep disturbances, and also in emotional lability. it is also used to stop the withdrawal syndrome in alcoholism and for supportive therapy during the remission period in chronic alcoholism, logoneurosis, and migraine.

Take orally or sublingually (without chewing) 20-50 mg 3 times a day, if necessary, gradually increasing the dose to 200 mg/day until a therapeutic effect is obtained.

A course dose of 100 mg/day is optimal. Appointment in higher daily doses (150-200 mg) may be accompanied by increased daytime sleepiness, a feeling of muscle weakness.

As a daytime tranquilizer, Gidazepam IC can be used to treat conditions with asthenic, depressive, phobic and hypochondriacal disorders in doses of 60-120 mg/day.

The average daily dose of the preparation in the treatment of patients with neurotic, neurotic, psychopathic, psychopathic conditions is 60-200 mg; with migraine - 40-60 mg.

To stop alcohol withdrawal, the initial dose is 50 mg, the average daily dose is 150 mg. The maximum daily dose during alcohol withdrawal is 500 mg.

The duration of the therapy course - from several days to 1-4 months - is determined by the doctor individually, depending on the patient's condition and the course of the disease.

The preparation can be used in outpatient practice.

Hypersensitivity to any of the components of the preparation. pronounced severe myasthenia gravis, significant liver function disorders (cirrhosis, Botkin's disease) and kidneys.

When using gidazepam in high doses or with increased individual sensitivity, some patients may experience symptoms characteristic of other tranquilizers of the group of benzodiazepine derivatives.

From the side of the nervous system: headache, drowsiness, lethargy, reduced speed of reactions, reduced attention and working capacity, general weakness, dizziness.

From the gastrointestinal tract: nausea.

From the musculoskeletal system: muscle weakness.

On the part of the skin: rash, itching, hyperemia of the skin, urticaria.

From the side of the immune system: allergic reactions, including angioedema.

Other: ataxia (a case of ataxia was reported in a patient that coincided with the use of gidazepam).

If adverse reactions occur, the dose should be reduced or the preparation should be discontinued.

It is necessary to limit the use of gidazepam in people with open-angle glaucoma, chronic renal failure and chronic liver failure, alcoholic liver damage.

The preparation contains lactose, so it should not be prescribed to patients with rare hereditary forms of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome.

The period of pregnancy and breastfeeding. The preparation should not be used during the specified period.

Children. The use of the preparation in children is contraindicated.

Influence on the ability to drive vehicles and work with other mechanisms. During the treatment period, it is necessary to refrain from activities that require increased attention and quick reaction.

Gidazepam ic is compatible with other psychotropic, hypnotic and anticonvulsant preparations. Hidazepam enhances the effect of phenamine, 5-oxytryptophan, enhances the effect of alcohol, sleeping pills, neuroleptics, and narcotic analgesics.

Possible occurrence of side effects characteristic of other tranquilizers of the benzodiazepine series - drowsiness, lethargy, dizziness, nausea, mild ataxia, allergic reactions. in these cases, it is necessary to reduce the dose of the preparation or cancel it.

The therapy is symptomatic.

At a temperature not higher than 25 °C.